# Alexandre Heraud

> Alexandre Heraud is a Series A investor at EQNX (Paris) backing Health Care and Medical Device. See 35 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [EQNX](https://shizune.co/investors/profile/eqnx)
- Location: Paris, France
- Total investments: 35
- Last investment: Sep 2025
- Lead investor: 43%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/alexandre-heraud-vc/
- X (Twitter): https://twitter.com/alexheraud99
- Website: http://www.anaxago.com

Alexandre Heraud is a Series A investor at EQNX in Paris focused on Health Care and Medical Device. Alexandre Heraud - Partner @ EQNX

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 10 | 29% |
| Medical Device | 5 | 14% |
| SaaS | 4 | 11% |
| Real Estate | 4 | 11% |
| Robotics | 3 | 9% |

65 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 12 | 34% |
| Funding Round | 6 | 17% |
| Series B | 5 | 14% |
| Seed | 4 | 11% |
| Series C | 3 | 9% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 20 | 57% |
| Belgium | 2 | 6% |
| Spain | 1 | 3% |
| Germany | 1 | 3% |
| Cameroon | 1 | 3% |

7 countries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sunrise | Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems. | $29.2M |  | Sep 25, 2025 |  |
| Kranus Health | Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently. | $5M | Series A | Mar 25, 2024 |  |
| Tilak Healthcare | Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases. | $10.5M | Series A | Oct 12, 2023 |  |
| Impress | Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020. |  | Series C | Nov 28, 2022 |  |
| Ganymed Robotics | Ganymed Robotics is a developer of advanced software and robotics technologies for orthopedic surgeons. | $21.4M | Series B | Jul 07, 2022 |  |
| Caravel Pension | Caravel Pension is dedicated to retirement to reinvent it and provide an answer to the new challenges of work and the urgency of Climate change. | $1.6M | Pre-Seed | Jun 08, 2022 |  |
| Unkle | Unkle is a one-stop-shop Insurtech startup for real estate.Unkle distributes 4 insurance products : A renter guarantee - a product created with an insurer - which offers renters to be their guarantor for a fee; A landlord guarantee : an insurance taken by landlords to protect their housing against unpaid rents A Home Insurance An Owner InsuranceUnkle's mission is to facilitate housing and make renting easier.Unkle is headquartered in Paris, France.Unkle est un broker digital (MGA) concevant les meilleurs produits d'assurance avec les assureurs pour leurs clients (B2C) et leurs partenaires (B2B2C). Unkle distribue 4 produits : - La garantie locataire : Unkle devient le garant des locataires qui sécurise gratuitement les propriétaires contre les loyers impayés. Chaque locataire peut avoir Unkle en tant que garant en moins de 3 minutes sur https://www.unkle.fr et avoir 10 fois plus de chances de louer son logement. - une assurance loyers impayés pour les propriétaires pour les protéger contre les loyers impayés - une assurance habitation - une assurance propriétaire non occupant | $11.4M | Series A | Jan 14, 2022 |  |
| Ledger | Ledger develops security and infrastructure solutions for cryptocurrencies as well as blockchain applications for individuals and companies, by leveraging a distinctive, proprietary technology.Launched in 2014, Ledger has designed an acclaimed line of hardware security devices quickly placing the company as a global leader on the market with1,000,000 units sold in more than 165 countries. For enterprises and corporations, Ledger introduced the Vault: a fully managed SaaS solution addressing the need to safeguard a very large amount of multiple cryptocurrencies while mitigating both IT and physical assault threats. The company is also active in the industrial IoT market, leveraging its secure hardware technology to interface sensors and machines to smart contracts or blockchain-based assets.Ledger is headquartered in Paris, has a production facility in Vierzon (France), and offices in San Francisco. | $380M | Series C | Jun 10, 2021 |  |
| OCUS | OCUS enables the world’s largest companies to seize the power and performance of visual content to grow their businesses and delight their customers. OCUS combines its technology with its creative community of 30,000 to deliver brand imagery at scale. | $24M | Series B | Apr 21, 2021 |  |
| OCUS | OCUS enables the world’s largest companies to seize the power and performance of visual content to grow their businesses and delight their customers. OCUS combines its technology with its creative community of 30,000 to deliver brand imagery at scale. | $24M | Series A | Apr 21, 2021 |  |

10 of 35 investments shown.

## Co-investors
- [Evolem Start](https://shizune.co/investors/profile/evolem-start) — VC Fund, 6 deals together
- [Anaxago](https://shizune.co/investors/profile/anaxago) — VC Fund, 5 deals together
- [CapHorn Invest](https://shizune.co/investors/profile/caphorn-invest) — VC Fund, 4 deals together
- [Expon Capital](https://shizune.co/investors/profile/expon-capital) — VC Fund, 4 deals together
- [noa](https://shizune.co/investors/profile/a-o-proptech) — VC Fund, 3 deals together
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 3 deals together

## About EQNX

VC Fund

EQNX helps early-stage to growth-stage firms revolutionize their industries and become global leaders.

4 contacts available at EQNX.

| Name | Title | Profile |
| --- | --- | --- |
| Alexandre Heraud | Partner | https://shizune.co/investors/profile/alexandre-heraud |
| François Santi | Parner | https://shizune.co/investors/profile/francois-santi |
| Gaston Vasseur | Principal | https://shizune.co/investors/profile/gaston-vasseur-daa4 |
| Paul Watel | Co-Founder & Principal | https://shizune.co/investors/profile/paul-watel-89f7 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Alexandre Heraud invest in?

Alexandre Heraud invests primarily in Health Care, Medical Device and SaaS startups, most often at Series A and Funding Round stage. Most of the 35 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Alexandre Heraud last invest?

The most recent investment recorded for Alexandre Heraud closed in Sep 2025. Shizune tracks 35 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co